Form 4 for ALT Altimmune, Inc.
Accepted 2026-02-02 00:00:00 ET · period of report 2026-01-31 · accession 0001960780-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-02 | 2026-01-31 | ALT | Jordt Raymond M | Chief Business Off | A - Grant | $3.07 | +4,571 | 70.1K | +7% | +$14.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2026-01-31 | A | A | 4,571 | $3.07 | 70,107 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2025. |